Genes & Cancer | CDK4: a master regulator of the cell cycle and its role in cancer

Genes & Cancer | December 2, 2022
PRESS RELEASE: A new review was published in Genes & Cancer on August 25, 2022, entitled, “CDK4: a master regulator of the cell cycle and its role in cancer.” continue reading »

Genes & Cancer | Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients

Genes & Cancer | November 18, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on February 10, 2022, entitled, “Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients.” continue reading »

The Role of CDKs in Breast Cancer Among Women in Pakistan

Genes & Cancer | October 28, 2022
Researchers examined the mRNA expression levels of six CDKs in Pakistani women with pre- and postmenopausal breast cancer with lung metastasis. continue reading »

Genes & Cancer | CDK4: a master regulator of the cell cycle and its role in cancer

News | December 2, 2022
PRESS RELEASE: A new review was published in Genes & Cancer on August 25, 2022, entitled, “CDK4: a master regulator of the cell cycle and its role in cancer.” continue reading »

Oncotarget | Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis

News | December 1, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on November 22, 2022, entitled, “Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis.” continue reading »

Aging | Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model

News | November 30, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 22, entitled, “Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model.” continue reading »

Oncotarget | Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis

Oncotarget | December 1, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on November 22, 2022, entitled, “Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis.” continue reading »

Oncotarget | Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more

Oncotarget | November 29, 2022
A new review was published in Oncotarget's Volume 13 on November 17, 2022, entitled, “Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more.” continue reading »

Oncotarget | Treasures from trash in cancer research

Oncotarget | November 23, 2022
PRESS RELEASE: On November 17, 2022, a new research perspective was published in Oncotarget, entitled, “Treasures from trash in cancer research.” continue reading »

Aging | Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model

Aging | November 30, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 22, entitled, “Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model.” continue reading »

Aging | Krill oil protects dopaminergic neurons from age-related degeneration through temporal transcriptome rewiring and suppression of several hallmarks of aging

Aging | November 23, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 21, entitled, “Krill oil protects dopaminergic neurons from age-related degeneration through temporal transcriptome rewiring and suppression of several hallmarks of aging.” continue reading »

Aging | The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability

Aging | November 21, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 21, entitled, “The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability.” continue reading »

Behind the Study: Novel TRKB Agonists Activate TRKB and Downstream ERK and AKT Signaling

Spotlight | November 1, 2022
Dr. Ya-Jen Chiu discusses a research paper she co-authored that was published by Aging (Aging-US), entitled, “Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity.” continue reading »

Behind the Study: Lotus Germ Extract Rejuvenates Aging Fibroblasts

Spotlight | October 26, 2022
Dr. Takushi Namba discusses a research paper he co-authored that was published by Aging (Aging-US), entitled, “Lotus germ extract rejuvenates aging fibroblasts via restoration of disrupted proteostasis by the induction of autophagy.” continue reading »

Behind the Study: Psychological Factors Substantially Contribute to Biological Aging in Chinese Cohort

Spotlight | October 18, 2022
Fedor Galkin, Scientific Director at Deep Longevity, Inc., discusses a research paper he co-authored that was published by Aging (Aging-US) in Volume 14, Issue 18, entitled, “Psychological factors substantially contribute to biological aging: evidence from the aging rate in Chinese older adults.” continue reading »

Behind the Study: Leveraging Scientific Findings to Develop Therapeutic Strategies for Dormant Breast Cancer Cells

Oncoscience | October 4, 2022
Alejandra Ferrer from the Department of Medicine-Hematology/Oncology at Rutgers New Jersey Medical School, describes a recent research perspective she co-authored that was published by Oncoscience, entitled, “Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells.” continue reading »

Oncoscience | As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression

Oncoscience | September 12, 2022
PRESS RELEASE: Dr. Blagosklonny published a new research commentary in Oncoscience, entitled, “As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression.” continue reading »

Oncoscience | SLFN11’s Surveillance Role in Protein Homeostasis

Oncoscience | August 3, 2022
PRESS RELEASE: A new research perspective was published on July 25, 2022, in Volume 9 of Oncoscience, entitled, “SLFN11’s surveillance role in protein homeostasis.” continue reading »